119 filings
Page 4 of 6
8-K
p03de vtkl4
23 Jul 21
Other Events
4:04pm
8-K
vugt0
15 Jul 21
Other Events
5:06pm
8-K
4klavo kcjqcq5cqc
28 Jun 21
Regulation FD Disclosure
4:15pm
8-K
qtx1 9ejzdkqz0xs580j
11 Jun 21
Other Events
6:21am
8-K
28q2 yxbk
7 Jun 21
Submission of Matters to a Vote of Security Holders
4:34pm
8-K
3aehpu4de7h 62
6 May 21
X4 Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
8:13am
8-K
mc9tjt29 wokjgtrel
9 Apr 21
Regulation FD Disclosure
4:09pm
8-K
vnare ztugz
19 Mar 21
X4 Pharmaceuticals Announces $55.0 Million At-the-Market Private Placement Financing
9:05am
8-K
8wckln4b
4 Mar 21
X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
8:23am
8-K
o5kq11thy9ws5x0
8 Jan 21
Regulation FD Disclosure
4:17pm
8-K
j2ithm5u
23 Dec 20
Entry into a Material Definitive Agreement
5:01pm
8-K
iwou5k9e
5 Nov 20
X4 Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
8:13am
8-K
zuyq46mshf0jpynvv76
16 Oct 20
Entry into a Material Definitive Agreement
4:16pm
8-K
ug0mfoohp67
7 Oct 20
Other Events
5:11pm
8-K
t5r90 5ph
1 Oct 20
X4 Pharmaceuticals Expands Board of Directors Through Appointment of Biopharmaceutical Industry Veteran Alison Lawton
8:31am
8-K
5gc7 s4ufvaiddww
11 Sep 20
Other Events
4:26pm
8-K
3ej2frif253s
30 Jul 20
X4 Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
8:11am
8-K
enxfs3l7ik6pdhmf34
11 Jun 20
Material Modifications to Rights of Security Holders
4:12pm
8-K
joqriw
7 May 20
X4 Pharmaceuticals Provides Corporate Update, Including Expected Impact of COVID-19, and Reports First Quarter 2020 Financial Results
8:04am
8-K
s67nl4yu1q4y 7jkcu
20 Mar 20
Departure of Directors or Certain Officers
4:06pm